Researchers receive £2.66M to test new immunotherapeutic strategy for non-small cell lung cancer
University of Liverpool researchers have secured £2.66m Medical Research Council funding to clinically test a novel immunotherapeutic strategy for non-small cell lung cancer – one of the most deadly cancers.
Source: news-medical.net